In vivo evaluation of the HeartWare centrifugal ventricular assist device

Texas Heart Institute Journal

Volumn 34, Issue 4, 2007, Pages 406-411

  Tuzun, Egemen ^a,b   Roberts, Katy ^a   Cohn, William E ^a   Sargin, Murat ^a   Gemmato, Courtney J ^a   Radovancevic, Branislav ^a   Frazier, O H ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

Author keywords

Animals; Assisted circulation instrumentation; Blood pump, centrifugal; Equipment design; Heart assist device, left ventricular; Hemodynamic processes; Heparin; Sheep; Thrombosis prevention control

Indexed keywords

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; AUTOPSY; BLOOD COMPATIBILITY; BLOOD PUMP; CENTRIFUGATION; CONTROLLED STUDY; DESCENDING AORTA; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HISTOPATHOLOGY; IMPLANTATION; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY INFARCTION; KIDNEY ISCHEMIA; LABORATORY TEST; LIVER FUNCTION; LIVER ISCHEMIA; LONG TERM CARE; NONHUMAN; RELIABILITY; SHEEP; THROMBUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; DISEASE MODELS, ANIMAL; ERYTHROCYTE COUNT; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMATOCRIT; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; REPRODUCIBILITY OF RESULTS; SHEEP;

EID: 37749002963     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Dembitsky WP, Tector AJ, Park S, Moskowitz AJ, Gelijns AC, Ronan NS, et al. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg 2004;78:2123-30.
2. Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC. Heart transplant and left ventricular assist device costs. J Heart Lung Transplant 2005;24:200-4.
3. Radovancevic B, Vrtovec B, Frazier OH. Left ventricular assist devices: an alternative to medical therapy for end-stage heart failure. Curr Opin Cardiol 2003;18:210-4.
4. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-43.
5. Schmid C, Welp H, Klotz S, Baba HA, Wilhelm MJ, Scheld HH. Outcome of patients surviving to heart transplantation after being mechanically bridged for more than 100 days. J Heart Lung Transplant 2003;22:1054-8.
6. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 2004;23:796-803.
7. Wohlschlaeger J, Schmitz KJ, Schmid C, Schmid KW, Keul P, Takeda A, et al. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res 2005;68:376-86.
8. Birks EJ, Tansley PD, Yacoub MH, Bowles CT, Hipkin M, Hardy J, et al. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 2004;23:964-9.
9. Dang NC, Topkara VK, Kim BT, Mercando ML, Kay J, Naka Y. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation. J Thorac Cardiovasc Surg 2005;130:1302-9.
10. Haddad M, Lam K, Hendry P, Mesana T, Davies R. Left ventricular assist devices for the treatment of congestive heart failure. Curr Treat Options Cardiovasc Med 2005;7:47-54.
11. Westaby S. Ventricular assist devices as destination therapy. Surg Clin North Am 2004;84:91-123.
12. Westaby S, Narula J. Surgical options in heart failure. Surg Clin North Am 2004;84:xv-xix.
13. Siegenthaler MP, Westaby S, Frazier OH, Martin J, Banning A, Robson D, et al. Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur Heart J 2005;26:1031-8.
14. Chinn R, Dembitsky W, Eaton L, Chillcott S, Stahovich M, Rasmusson B, Pagani F. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 2005;51:461-70.
15. Eckhauser AE, Melvin WV, Sharp KW. Management of general surgical problems in patients with left ventricular assist devices. Am Surg 2006;72:158-61.
16. Frazier OH. The development of an implantable, portable, electrically powered left ventricular assist device. Semin Thorac Cardiovasc Surg 1994;6:181-7.
17. Frazier OH. Outpatient LVAD: its time has arrived. Ann Thorac Surg 1994;58:1309-10.
18. Martin J, Friesewinkel O, Benk C, Sorg S, Schultz S, Beyersdorf F. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year. J Heart Lung Transplant 2006;25:384-90.
19. Simon D, Fischer S, Grossman A, Downer C, Hota B, Heroux A, Trenholme G. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 2005;40:1108-15.
20. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg 2004;77:133-42.
21. Radovancevic B, Gregoric ID, Tamez D, Vrtovec B, Tuzun E, Chee HK, et al. Biventricular support with the Jarvik 2000 axial flow pump: a feasibility study. ASAIO J 2003;49:604-7.
22. Saito S, Nishinaka T, Westaby S. Hemodynamics of chronic nonpulsatile flow: implications for LVAD development. Surg Clin North Am 2004;84:61-74.
23. Saito S, Westaby S, Piggot D, Dudnikov S, Robson D, Catarino PA, et al. End-organ function during chronic nonpulsatile circulation. Ann Thorac Surg 2002;74:1080-5.
24. Horton SC, Khodaverdian R, Powers A, Revenaugh J, Renlund DG, Moore SA, et al. Left ventricular assist device malfunction: a systematic approach to diagnosis. J Am Coll Cardiol 2004;43:1574-83.
25. Kirklin JK, Holman WL. Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances). Curr Opin Cardiol 2006;21:120-6.
26. Nakata K, Yoshikawa M, Takano T, Maeda T, Nonaka K, Linneweber J, et al. Antithrombogenicity evaluation of a centrifugal blood pump. Artif Organs 2000;24:667-70.
27. Reilly MP, Wiegers SE, Cucchiara AJ, O'Hara ML, Plappert TJ, Loh E, et al. Frequency, risk factors, and clinical outcomes of left ventricular assist device-associated ventricular thrombus. Am J Cardiol 2000;86:1156-9, A10.
28. Rose AG, Park SJ. Pathology in patients with ventricular assist devices: a study of 21 autopsies, 24 ventricular apical core biopsies and 24 explanted hearts. Cardiovasc Pathol 2005;14:19-23.
29. Nakazawa T, Makinouchi K, Takami Y, Glueck J, Takatani S, Nose Y. The effect of the impeller-driver magnetic coupling distance on hemolysis in a compact centrifugal pump. Artif Organs 1996;20:252-7.
30. Takami Y, Nakazawa T, Makinouchi K, Glueck J, Benkowski R, Nose Y. Effect of surface roughness on hemolysis in a centrifugal blood pump. ASAIO J 1996;42:M858-62.
31. Tuzun E, Gregoric ID, Conger JL, Golden K, Jarvik R, Frazier OH, Kadipasaoglu KA. The effect of intermittent low speed mode upon aortic valve opening in calves supported with a Jarvik 2000 axial flow device. ASAIO J 2005;51:139-43.
32. Yoshikawa M, Nakata K, Takano T, Maeda T, Glueck J, Murabayashi S, et al. Development of an implantable small right ventricular assist device. ASAIO J 2000;46:338-43.
33. Frazier OH, Gregoric ID, Cohn WE. Initial experience with non-thoracic, extraperitoneal, off-pump insertion of the Jarvik 2000 heart in patients with previous median sternotomy. J Heart Lung Transplant 2006;25:499-503.
34. Myers TJ, Frazier OH, Mesina HS, Radovancevic B, Gregoric ID. Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. J Heart Lung Transplant 2006;25:379-83.